CD66c/e Mouse Monoclonal Antibody [Clone ID: MUS] DM1203 from OriGene Technologies | Biocompare.com

Supplier Images

CD66c/e Mouse Monoclonal Antibody [Clone ID: MUS]

Be the first to write a review!

Citations:

Supplier Page from
OriGene Technologies for
CD66c/e Mouse Monoclonal Antibody [Clone ID: MUS]

OriGene Technologies' CD66c/e Mouse Monoclonal Antibody [Clone ID: MUS] is a Mouse monoclonal antibody. It reacts with Human. This antibody has been shown to work in applications such as: EIA, Immunoassay, ELISA, Flow Cytometry, Immunofluorescence, Immunohistochemistry, and Western Blot.

Description

CD66c/e mouse monoclonal antibody, clone MUS, Purified

Product Specs
ItemCD66c/e Mouse Monoclonal Antibody [Clone ID: MUS]
CompanyOriGene Technologies
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberDM1203
Quantity100 µg
ApplicationsELISA, FC, IF, IHC, WB
Concentrationlot specific
Conjugate/TagUnconjugated
PurityAffinity Chromatography on Protein G
ReactivityHuman
IsotypeIgG1
CloneMUS
HostMouse
Antibody TypePrimary Antibodies
ImmunogenMUS was generated by immunisation of BALB/c mice with CEA partially purified from a perchloric acid extract from liver metastases of colonic tumors (3)
Brand/TrademarkAcris Antibodies GmbH
ClonalityMonoclonal
TypePrimary Antibodies
FormatPhosphate buffered saline, pH 7.2
State: Purified
State: Liquid purified IgG fraction

Add to Compare List

OriGene Technologies

OriGene Technologies

9620 Medical Center Drive # 200

Rockville, Maryland 20850

United States

Phone: 1-888-267-4436 (U.S. only) / 301-340-3188
301-340-9254

Company Profile

Website: http://www.origene.com

(1) RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cellsClinical cancer research : an official journal of the American Association for Cancer ResearchMay 15, 2006Hideaki Tsutsumida, Benjamin J Swanson, Pankaj K Singh, Thomas C Caffrey, Shinichi Kitajima, Masamichi Goto, Suguru Yonezawa, Michael A Hollingsworth

(2) RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cellsClinical cancer research : an official journal of the American Association for Cancer ResearchMay 15, 2006Tsutsumida H, Swanson BJ, Singh PK, Caffrey TC, Kitajima S, Goto M, Yonezawa S, Hollingsworth MA.

Be the First to Write a Review!